Coronary Interventions

View from the Thoraxcenter: ACC.23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 33m 36s
ACC.23 Late-Breaker Discussion: The BIOVASC Trial

Harriette Van Spall, Roberto Diletti,

Watch time: 12m 7s
ACC 23: RENOVATE-COMPLEX-PCI: IVUS Vs OCT Optimisation in Complex PCI

Joo-Yong Hahn,

Watch time: 5m 38s
ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s
View from the Thoraxcenter: What's Hot at ACC.23?

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 22m 4s
Use of Cerebral Embolic Protection in 2023

Vijay Kunadian, Richard J Jabbour, Rajesh Kharbanda, et al

Watch time: 24m 10s
AHA 22: 4 Trials That Will Change Your Practice With Interventionalist, Dr Alasnag

Mirvat Alasnag,

Watch time: 12m 38s
AHA 22 Late-Breaking Science Highlights With Dr Joseph Hill

Joseph A Hill,

Watch time: 5m 44s

Chandan Deepak Bhavnani , Alan Yean Yip Fong , Keng Tat Koh , et al

Read time: 12 Min
View from the Thoraxcenter: AHA 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 15m 30s

Wan Azman Wan Ahmad , Edouard Benit , Cyril Camaro , et al

Read time: 15 min
View from the Thoraxcenter: TCT 22 Late-breaking Science Wrap-up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 37m 13s

Nicolas M Van Mieghem, Simone Biscaglia, Ajay J Kirtane, et al

Watch time: 2h 20m 24s (21 videos)

Wan Azman Wan Ahmad , Edouard Benit , Victor M Legrand , et al

View from the Thoraxcenter: ESC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 24m 27s
TWILIGHT-HBR: Ticagrelor Monotherapy in HBR Patients Undergoing PCI

Davide Cao,

Watch time: 8m 40s
TRISCEND Study: 6Mo Outcomes Show TR Reduction in Majority of Patients

Susheel Kodali,

Watch time: 7m 27s
View from the Thoraxcanter: ACC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 23m 9s
STOPDAPT-2 ACT: 1-month DAPT Followed by Clopidogrel Monotherapy in ACS

Hirotoshi Watanabe,

Watch time: 5m 43s
ACC 22: FFR vs. IVUS-guided PCI in Intermediate Coronary Artery Stenosis: The FLAVOUR Trial

Bon-Kwon Koo,

Watch time: 9m 27s
View from the Thoraxcenter: AHA 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 15m 30s
View from the Thoraxcenter – What's Hot at ESC 2021

Joost Daemen, Nicolas M Van Mieghem,

Watch time: 25m 18s
FAME3: PCI Guided by FFR Didn't Meet Noninferiority for 1Y Outcomes Compared to CABG

William Fearon,

Watch time: 10m 32s
View from the Thoraxcenter: ESC 21 Late-breaking Science Wrap Up

Joost Daemen, Nicolas M Van Mieghem,

Watch time: 36m 1s

Media

ACC.23 Late-Breaker Discussion: The BIOVASC Trial

Harriette Van Spall, Roberto Diletti,

Watch time: 12m 7s
ACC 23: RENOVATE-COMPLEX-PCI: IVUS Vs OCT Optimisation in Complex PCI

Joo-Yong Hahn,

Watch time: 5m 38s
ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s
View from the Thoraxcenter: What's Hot at ACC.23?

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 22m 4s
Use of Cerebral Embolic Protection in 2023

Vijay Kunadian, Richard J Jabbour, Rajesh Kharbanda, et al

Watch time: 24m 10s
AHA 22: 4 Trials That Will Change Your Practice With Interventionalist, Dr Alasnag

Mirvat Alasnag,

Watch time: 12m 38s
View from the Thoraxcenter: AHA 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 15m 30s
View from the Thoraxcenter: TCT 22 Late-breaking Science Wrap-up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 37m 13s

Nicolas M Van Mieghem, Simone Biscaglia, Ajay J Kirtane, et al

Watch time: 2h 20m 24s (21 videos)
ACC 22: 5 Trials That Will Change Your Practice with Interventionist, Dr Mirvat Alasnag

Mirvat Alasnag,

Watch time: 6m 15s
ACC 22: FFR vs. IVUS-guided PCI in Intermediate Coronary Artery Stenosis: The FLAVOUR Trial

Bon-Kwon Koo,

Watch time: 9m 27s
View from the Thoraxcanter: ACC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 23m 9s
USC Discussion: Hemodynamics in Cardiogenic Shock

Alexander G Truesdell, Jaime A Hernandez-Montfort, Varinder Kaur Randhawa, et al

Watch time: 19m 11s
View from the Thoraxcenter: TCT 21 Late-breaking Science Wrap Up

Joost Daemen, Nicolas M Van Mieghem,

Watch time: 22m 33s
View from the Thoraxcenter: AHA 21 Late-breaking Science Preview

Joost Daemen, Nicolas M Van Mieghem,

Watch time: 9m 51s
TCT 21: SCB Shows Similar Angiographic Outcomes to Paclitaxel DCB

Bruno Scheller,

Watch time: 8m 8s
TRISCEND Study: 6Mo Outcomes Show TR Reduction in Majority of Patients

Susheel Kodali,

Watch time: 7m 27s
SUGAR: Amphilimus-eluting Stents VS Zotarolimus-eluting Stents in Patients With DB

Rafael Romaguera,

Watch time: 8m 19s
iFR-SWEDEHEART: No Difference in Outcome at 5-yrs of iFR vs FFR

Matthias Gotberg,

Watch time: 4m 40s
FAME3: PCI Guided by FFR Didn't Meet Noninferiority for 1Y Outcomes Compared to CABG

William Fearon,

Watch time: 10m 32s
View from the Thoraxcenter: TCT 21 Late-breaking Science Preview

Joost Daemen, Nicolas M Van Mieghem,

Watch time: 22m 43s
View from the Thoraxcenter: ESC 21 Late-breaking Science Wrap Up

Joost Daemen, Nicolas M Van Mieghem,

Watch time: 36m 1s
Cardio-oncology Discussion: Primary PCI in Cancer Patients

Arjun K Ghosh, Deepak L Bhatt, Cezar Iliescu, et al

Watch time: 36m 6s
TWILIGHT-Stent: Ticagrelor Monotherapy According to Stent Type

George D Dangas,

Watch time: 9m
STOPDAPT-2 ACT: 1-month DAPT Followed by Clopidogrel Monotherapy in ACS

Hirotoshi Watanabe,

Watch time: 5m 43s
TWILIGHT-HBR: Ticagrelor Monotherapy in HBR Patients Undergoing PCI

Davide Cao,

Watch time: 8m 40s
SYNTAX II Trial: 5yr Data Shows Reduction in MACE in PCI

Adrian P Banning,

Watch time: 4m 39s
ENVISAGE-TAVI AF: Edoxaban noninferior to warfarin for adverse events after TAVI

George D Dangas,

Watch time: 6m 33s
View from the Thoraxcenter – What's Hot at ESC 2021

Joost Daemen, Nicolas M Van Mieghem,

Watch time: 25m 18s

Bill D Gogas, ,

Watch time: 36m 41s (2 videos)

Media

View from the Thoraxcenter: ACC.23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 33m 36s
ACC.23 Late-Breaker Discussion: The BIOVASC Trial

Harriette Van Spall, Roberto Diletti,

Watch time: 12m 7s
ACC 23: RENOVATE-COMPLEX-PCI: IVUS Vs OCT Optimisation in Complex PCI

Joo-Yong Hahn,

Watch time: 5m 38s
ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s
View from the Thoraxcenter: What's Hot at ACC.23?

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 22m 4s
Use of Cerebral Embolic Protection in 2023

Vijay Kunadian, Richard J Jabbour, Rajesh Kharbanda, et al

Watch time: 24m 10s
AHA 22: 4 Trials That Will Change Your Practice With Interventionalist, Dr Alasnag

Mirvat Alasnag,

Watch time: 12m 38s
AHA 22 Late-Breaking Science Highlights With Dr Joseph Hill

Joseph A Hill,

Watch time: 5m 44s
View from the Thoraxcenter: AHA 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 15m 30s
View from the Thoraxcenter: TCT 22 Late-breaking Science Wrap-up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 37m 13s
View from the Thoraxcenter: ESC 22 Late-breaking Science Wrap-up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 33m 19s
View from the Thoraxcenter: ESC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 24m 27s

Nicolas M Van Mieghem, Simone Biscaglia, Ajay J Kirtane, et al

Watch time: 2h 20m 24s (21 videos)
ACC 22: 5 Trials That Will Change Your Practice with Interventionist, Dr Mirvat Alasnag

Mirvat Alasnag,

Watch time: 6m 15s
ACC 22: FFR vs. IVUS-guided PCI in Intermediate Coronary Artery Stenosis: The FLAVOUR Trial

Bon-Kwon Koo,

Watch time: 9m 27s
View from the Thoraxcanter: ACC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 23m 9s
USC Discussion: Hemodynamics in Cardiogenic Shock

Alexander G Truesdell, Jaime A Hernandez-Montfort, Varinder Kaur Randhawa, et al

Watch time: 19m 11s
OPTIMUM Registry: PCI in Patients at Prohibitive Risk for CABG

David Kandzari,

Watch time: 10m 19s
View from the Thoraxcenter: TCT 21 Late-breaking Science Wrap Up

Joost Daemen, Nicolas M Van Mieghem,

Watch time: 22m 33s
View from the Thoraxcenter: AHA 21 Late-breaking Science Preview

Joost Daemen, Nicolas M Van Mieghem,

Watch time: 9m 51s
TCT 21: SCB Shows Similar Angiographic Outcomes to Paclitaxel DCB

Bruno Scheller,

Watch time: 8m 8s
TRISCEND Study: 6Mo Outcomes Show TR Reduction in Majority of Patients

Susheel Kodali,

Watch time: 7m 27s
SUGAR: Amphilimus-eluting Stents VS Zotarolimus-eluting Stents in Patients With DB

Rafael Romaguera,

Watch time: 8m 19s
iFR-SWEDEHEART: No Difference in Outcome at 5-yrs of iFR vs FFR

Matthias Gotberg,

Watch time: 4m 40s
FAME3: PCI Guided by FFR Didn't Meet Noninferiority for 1Y Outcomes Compared to CABG

William Fearon,

Watch time: 10m 32s
View from the Thoraxcenter: TCT 21 Late-breaking Science Preview

Joost Daemen, Nicolas M Van Mieghem,

Watch time: 22m 43s
View from the Thoraxcenter: ESC 21 Late-breaking Science Wrap Up

Joost Daemen, Nicolas M Van Mieghem,

Watch time: 36m 1s
Cardio-oncology Discussion: Primary PCI in Cancer Patients

Arjun K Ghosh, Deepak L Bhatt, Cezar Iliescu, et al

Watch time: 36m 6s
TWILIGHT-Stent: Ticagrelor Monotherapy According to Stent Type

George D Dangas,

Watch time: 9m
STOPDAPT-2 ACT: 1-month DAPT Followed by Clopidogrel Monotherapy in ACS

Hirotoshi Watanabe,

Watch time: 5m 43s

Articles

12-month Outcomes of CAFFR-guided PCI Deferral

Chandan Deepak Bhavnani

,

Alan Yean Yip Fong

,

Keng Tat Koh

,

Ing Xiang Pang

,

Lean Seng Chen

,

Hwei Sung Ling

,

Lee Karl Thien

,

Chung Bui Khiong

,

Chen Ting Tan

,

Yen Yee Oon

,

Kian Hui Ho

,

Francis Eng Pbeng Shu

,

Asri Said

,

Yee Ling Cham

,

Tiong Kiam Ong

,

Published:

04 November 2022

Citation:

Journal of Asian Pacific Society of Cardiology 2022;1:e28.

DOI:

https://doi.org/10.15420/japsc.2022.14
  • Views: Views 476
  • Downloads: Downloads 12
  • Read time: 12 Min

Asian Versus European Patients Treated With COMBO Stent in the REDUCE Trial

Wan Azman Wan Ahmad

,

Edouard Benit

,

Cyril Camaro

,

Elvin Kedhi

,

Saman Rasoul

,

Lucia Barbieri

,

Jacques Lalmand

,

René J van der Schaaf

,

Tian H Koh

,

Arnoud W van‘t Hof

,

Stephen W Lee

,

Vincent Roolvink

,

Marc A Brouwer

,

Giuseppe DeLuca

,

Harry Suryapranata

,

Published:

13 October 2022

Citation:

Journal of Asian Pacific Society of Cardiology 2022;1:e25.

DOI:

https://doi.org/10.15420/japsc.2022.02
  • Views: Views 216
  • Downloads: Downloads 11
  • Read time: 15 min

PIELD Study

Ganapathi Palaniappan

,

Rhuban M Sundran

,

Afif Ashari

,

Mohd Saad Jalaluddin

,

Afrah Yousif Haroon

,

Rohith Stanislaus

,

Yee Sin Tey

,

Ahmad Farhan Abdul Hamid

,

Tjen Jhung Lee

,

Shaiful Azmi Yahaya

,

Balachandran Kandasamy

,

Zulaikha Zainal

,

Published:

12 September 2022

Citation:

Journal of Asian Pacific Society of Cardiology 2022;1:e20.

DOI:

https://doi.org/10.15420/japsc.2021.34
  • Views: Views 465
  • Downloads: Downloads 21

DAPT in NSTEMI/UA or STEMI: Analysis of REDUCE

Wan Azman Wan Ahmad

,

Edouard Benit

,

Victor M Legrand

,

Achmad Fauzi Yahya

,

Huay Cheem Tan

,

Sodiqur Rifqi

,

Muhamad Ali SK Abdul Kader

,

Bruno Pironi

,

Robbert J de Winter

,

Chor-Cheung Frankie Tam

,

Eric Ligtenberg

,

Giuseppe DeLuca

,

Harry Suryapranata

,

Published:

29 July 2022

Citation:

Journal of Asian Pacific Society of Cardiology 2022;1:e18.

DOI:

https://doi.org/10.15420/japsc.2021.29
  • Views: Views 1480
  • Downloads: Downloads 49